© 2024 WYPR
WYPR 88.1 FM Baltimore WYPF 88.1 FM Frederick WYPO 106.9 FM Ocean City
Donate
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

High Drug Costs: Industry Perspective

By Jennifer Ludden
Published October 17, 2004 at 12:00 AM EDT

NPR's Jennifer Ludden talks with Dr. Paul Antony, chief medical officer for the Pharmaceutical Research and Manufacturers of America. He offers the drug industry's perspective on the rising costs of prescription drugs, and responds to charges made Saturday by Dr. Marcia Angell, who accuses pharmaceutical companies of spending too much on advertising and making undue profits.

Copyright 2004 NPR
Jennifer Ludden
Jennifer Ludden helps edit energy and environment stories for NPR's National Desk, working with NPR staffers and a team of public radio reporters across the country. They track the shift to clean energy, state and federal policy moves, and how people and communities are coping with the mounting impacts of climate change.
See stories by Jennifer Ludden